Xeris Biopharma Holdings Inc (XERS) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
Xeris Biopharma Holdings Inc   (NASDAQ: XERS)
 

Xeris Biopharma Holdings Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the second quarter 2026, Xeris Biopharma Holdings Inc 's inventory turnover ratio sequentially decreased to 0.62 in the second quarter 2026, unsurprisingly, as the Xeris Biopharma Holdings Inc markets continue to deteriorate, and XERS's faces growing challenges to bring down its inventories. Xeris Biopharma Holdings Inc 's average inventory processing period in the Jun 30 2026 quarter, has increased to 589 days, from 570 days, in the Mar 31 2026 quarter.

Within Healthcare sector 344 other companies have achieved higher inventory turnover ratio. While inventory turnover ranking remained unchanged in the Second Quarter 2026 compared to previous quarter at no. 1628.

XERS Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Xeris Biopharma Holdings Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

XERS Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth 20.28 % 40.89 % 42.55 % 49.52 % 56.55 %
Y / Y Cost of Sales Growth 5.16 % 21.15 % 15.5 % -19.11 % 52.73 %
Inventory Turnover Ratio (TTM) 0.62 0.64 0.66 0.7 0.82
XERS's Total Ranking # 1628 # 1628 # 1143 # 1182 # 1425
Average inventory processing period 590 570 549 523 445
Seq. Inventory Growth 9.02 % 8.1 % 1.8 % 0.27 % 27.69 %
Seq. Cost of Sales Growth 18.33 % -3.41 % -0.45 % -7.58 % 36.32 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 106
Healthcare Sector # 345
Overall Market # 1628

Inventory Turnover Ratio Statistics
High Average Low
1.81 0.98 0.62
(Sep 30 2020)   (Jun 30 2026)



XERS Company Profile >> Back to XERS Efficiency Comparisons >> Compare XERS Inventory Turnover Ratio to its Competitors

Financial Statements
Xeris Biopharma Holdings Inc 's Inventories $ 81 Millions Visit XERS's Balance sheet
Xeris Biopharma Holdings Inc 's Cost of Revenues TTM $ 45 Millions Visit XERS's Income Statement
What are XERS's Sales? Visit XERS's Sales by Segment

Other Inventory Turnover Ratios
Xeris Biopharma Holdings Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
XERS's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for XERS's Competitors
Inventory Turnover Ratio for XERS's Suppliers
Inventory Turnover Ratio for XERS's Customers

You may also want to know
XERS's Sales Growth Rates XERS's Pe Price to earnings ratio XERS's Receivables Turnover Ratio XERS's Stock Quote
XERS's Net Income Growth Rates XERS's Ps Price to Sales ratio XERS's Sales per Employee XERS's Asset Turnover Ratio
XERS's Net Margin XERS's Pb Price to Book ratio XERS's Financial Strength Ratios XERS's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Staar Surgical Co  1.53 $ 79.388  Millions$ 52  Millions
Abeona Therapeutics Inc   1.51 $ 8.405  Millions$ 6  Millions
Enovis Corp  1.50 $ 898.682  Millions$ 601  Millions
Axogen inc   1.45 $ 63.909  Millions$ 44  Millions
Cv Sciences Inc   1.45 $ 5.804  Millions$ 4  Millions
Nuwellis Inc   1.43 $ 2.732  Millions$ 2  Millions
Mannkind Corporation  1.43 $ 55.824  Millions$ 39  Millions
Insmed Inc  1.43 $ 188.217  Millions$ 132  Millions
Teleflex Incorporated  1.42 $ 689.171  Millions$ 485  Millions
Cormedix Inc   1.42 $ 45.432  Millions$ 32  Millions
Cumberland Pharmaceuticals Inc   1.41 $ 5.164  Millions$ 4  Millions
Standard Biotools Inc   1.41 $ 28.569  Millions$ 20  Millions
Sight Sciences Inc   1.41 $ 10.014  Millions$ 7  Millions
Outset Medical Inc   1.40 $ 67.951  Millions$ 48  Millions
Biocorrx Inc   1.40 $ 0.170  Millions$ 0  Millions
Lensar Inc   1.38 $ 31.126  Millions$ 23  Millions
Arcutis Biotherapeutics Inc   1.35 $ 41.096  Millions$ 30  Millions
Alphatec Holdings Inc   1.32 $ 237.415  Millions$ 179  Millions
Elanco Animal Health Incorporated  1.29 $ 2,241.000  Millions$ 1,733  Millions
Xtant Medical Holdings Inc   1.28 $ 43.701  Millions$ 34  Millions
Edwards Lifesciences Corporation  1.28 $ 1,443.400  Millions$ 1,129  Millions
Globus Medical Inc   1.27 $ 989.145  Millions$ 779  Millions
Karyopharm Therapeutics Inc   1.27 $ 4.942  Millions$ 4  Millions
Clene Inc   1.25 $ 0.059  Millions$ 0  Millions
Si bone inc   1.24 $ 44.462  Millions$ 36  Millions
Kyntra Bio Inc   1.24 $ 4.444  Millions$ 4  Millions
Pulmonx Corporation  1.24 $ 20.014  Millions$ 16  Millions
Biolife Solutions Inc   1.24 $ 39.035  Millions$ 32  Millions
Stereotaxis Inc   1.23 $ 13.184  Millions$ 11  Millions
60 Degrees Pharmaceuticals Inc   1.20 $ 0.895  Millions$ 1  Millions

Date modified: 2026-09-05T15:41:01+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.